Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Virginia Eye Consultants

Neither a doctor nor a teaching hospital

Research payments

$467,580

65 payments

Through program year 2025, Virginia Eye Consultants is reported as receiving $467,580 in research payments, across 65 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $8,995 1
2024 Research $4,200 1
2023 Research $78,008 24
2022 Research $58,911 4
2021 Research $125,776 8
2020 Research $64,220 7
2019 Research $127,470 20

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novartis Pharmaceuticals Corporation $208,180 11 payments
  2. Johnson & Johnson Surgical Vision, Inc. $129,900 18 payments
  3. Alcon Research LLC $61,441 6 payments
  4. Bausch Health US, LLC $17,390 4 payments
  5. Glaukos Corporation $14,839 10 payments
  6. Medtronic, Inc. $9,885 7 payments
  7. Genentech, Inc. $8,995 1 payment
  8. Kala Pharmaceuticals, Inc. $6,750 5 payments
  9. Mallinckrodt Enterprises LLC $5,500 1 payment
  10. Bausch & Lomb Americas Inc. $4,700 2 payments
Studies the money was for Research payments · program years 2019–2025
  1. A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of Brolucizumab VS. Aflibercept in Patients With Visual Impairment Due to Diabetic MacUlar Edema (Kingfisher) $80,263 2 payments
  2. Evaluation of the Meibomian Gland Architecture in Cataract Surgery $69,300 3 payments
  3. Clinical Investigation of the Bacterially-Derived Healon EndoCoat PRO Ophthalmic Viscosurgical Device (OVD) $56,000 11 payments
  4. A 96-Week, Two-Arm, Randomized, Single-Masked, Multi-Center, Phase III Study Assessing the Efficacy and Safety of Brolucizumab 6 MG Compared to Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy $55,219 5 payments
  5. Phase II Study Unr844 1.5% in Subjects With Presbyopia $42,494 1 payment
  6. Clinical Investigation of AcrySof IQ PanOptix Presbyopia Correcting Intraocular Lens (IOL) Model TFNT00 -- US $30,858 2 payments
  7. Evaluation of the Clinical Efficacy and Tolerability of SYSTANE Complete in Adult Patients With Dry Eye Disease Following Topical Ocular Use for 4 Weeks: A Multicenter Trial $30,582 4 payments
  8. A Randomized, Double-Masked, Multicenter Study to Evaluate the Safety and Efficacy of Ecf843 VS Vehicle in Subjects With Dry Eye Disease $30,204 3 payments
  9. A Phase 3, Multi-Center, Randomized, Double-Masked, Saline-Controlled Trial to Evaluate the Effect of NOV03 (Perfluorohexyloctane) on Signs and Symptoms of Dry Eye Disease Associated with Meibomian Gland Dysfunction (Mojave Study) $16,890 3 payments
  10. A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery $14,839 10 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record